Polarean Imaging Plc (POLX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Polarean Imaging Plc (POLX) has a cash flow conversion efficiency ratio of -0.473x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-3.74 Million ≈ $-454.69 USD) by net assets (GBX7.90 Million ≈ $961.80 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see POLX market cap for the company's overall valuation and market capitalisation.
Polarean Imaging Plc - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Polarean Imaging Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Polarean Imaging Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Polarean Imaging Plc ranked by their cash flow conversion efficiency. See Polarean Imaging Plc debt service capacity to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HYGEIA HC HLDGS DL-00001
F:50I
|
0.009x |
|
New Horizon Group Ltd
TA:NERZ
|
0.007x |
|
Plaza Centers NV
LSE:PLAZ
|
0.002x |
|
PureCycle Technologies Inc
NASDAQ:PCTTW
|
-0.564x |
|
Mingzhu Logistics Holdings Ltd
NASDAQ:YGMZ
|
0.030x |
|
Bluebird Merchant Ventures Ltd
LSE:BMV
|
0.000x |
|
Spacefy Inc
F:YSP
|
0.002x |
|
KRUNGTHAI CARD FGN BA 1
F:KRTA
|
-0.012x |
Annual Cash Flow Conversion Efficiency for Polarean Imaging Plc (2016–2024)
The table below shows the annual cash flow conversion efficiency of Polarean Imaging Plc from 2016 to 2024. View POLX stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX12.14 Million ≈ $1.48K |
GBX-4.17 Million ≈ $-507.80 |
-0.344x | +72.67% |
| 2023-12-31 | GBX8.30 Million ≈ $1.01K |
GBX-10.43 Million ≈ $-1.27K |
-1.257x | -98.04% |
| 2022-12-31 | GBX19.30 Million ≈ $2.35K |
GBX-12.26 Million ≈ $-1.49K |
-0.635x | -64.50% |
| 2021-12-31 | GBX31.74 Million ≈ $3.86K |
GBX-12.25 Million ≈ $-1.49K |
-0.386x | +41.83% |
| 2020-12-31 | GBX8.73 Million ≈ $1.06K |
GBX-5.79 Million ≈ $-705.05 |
-0.664x | +33.29% |
| 2019-12-31 | GBX4.59 Million ≈ $558.48 |
GBX-4.57 Million ≈ $-555.51 |
-0.995x | -65.73% |
| 2018-12-31 | GBX7.79 Million ≈ $947.99 |
GBX-4.68 Million ≈ $-568.98 |
-0.600x | +21.06% |
| 2017-12-31 | GBX3.44 Million ≈ $418.60 |
GBX-2.62 Million ≈ $-318.25 |
-0.760x | -158.60% |
| 2016-12-31 | GBX-585.75K ≈ $-71.27 |
GBX-759.99K ≈ $-92.47 |
1.297x | -- |
About Polarean Imaging Plc
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent ind… Read more